nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—DPP9—mammary gland—breast cancer	0.0502	0.21	CbGeAlD
Vildagliptin—DPP9—pituitary gland—breast cancer	0.0227	0.0948	CbGeAlD
Vildagliptin—DPP9—adipose tissue—breast cancer	0.0226	0.0944	CbGeAlD
Vildagliptin—DPP9—adrenal gland—breast cancer	0.0203	0.0846	CbGeAlD
Vildagliptin—DPP9—female gonad—breast cancer	0.0189	0.0789	CbGeAlD
Vildagliptin—Saxagliptin—ABCC1—breast cancer	0.0162	0.791	CrCbGaD
Vildagliptin—DPP4—embryo—breast cancer	0.0131	0.0547	CbGeAlD
Vildagliptin—DPP9—lymph node—breast cancer	0.0122	0.0507	CbGeAlD
Vildagliptin—DPP4—epithelium—breast cancer	0.0107	0.0447	CbGeAlD
Vildagliptin—DPP4—endometrium—breast cancer	0.00959	0.04	CbGeAlD
Vildagliptin—DPP4—uterus—breast cancer	0.00884	0.0369	CbGeAlD
Vildagliptin—DPP4—adipose tissue—breast cancer	0.00865	0.0361	CbGeAlD
Vildagliptin—DPP4—female reproductive system—breast cancer	0.00795	0.0332	CbGeAlD
Vildagliptin—DPP4—adrenal gland—breast cancer	0.00776	0.0324	CbGeAlD
Vildagliptin—DPP4—bone marrow—breast cancer	0.0075	0.0313	CbGeAlD
Vildagliptin—DPP4—female gonad—breast cancer	0.00723	0.0302	CbGeAlD
Vildagliptin—DPP4—endocrine gland—breast cancer	0.00673	0.0281	CbGeAlD
Vildagliptin—DPP4—lymph node—breast cancer	0.00465	0.0194	CbGeAlD
Vildagliptin—Saxagliptin—CYP3A4—breast cancer	0.00426	0.209	CrCbGaD
Vildagliptin—Fatigue—Vinorelbine—breast cancer	0.000843	0.00114	CcSEcCtD
Vildagliptin—Arthralgia—Mitoxantrone—breast cancer	0.000841	0.00114	CcSEcCtD
Vildagliptin—Angiopathy—Paclitaxel—breast cancer	0.000839	0.00113	CcSEcCtD
Vildagliptin—Constipation—Vinorelbine—breast cancer	0.000836	0.00113	CcSEcCtD
Vildagliptin—Chills—Paclitaxel—breast cancer	0.00083	0.00112	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Docetaxel—breast cancer	0.000826	0.00112	CcSEcCtD
Vildagliptin—Asthenia—Tamoxifen—breast cancer	0.00082	0.00111	CcSEcCtD
Vildagliptin—Arthralgia—Gemcitabine—breast cancer	0.000819	0.00111	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000813	0.0011	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Doxorubicin—breast cancer	0.00081	0.00109	CcSEcCtD
Vildagliptin—Oedema—Mitoxantrone—breast cancer	0.000806	0.00109	CcSEcCtD
Vildagliptin—Oedema—Irinotecan—breast cancer	0.000806	0.00109	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Thiotepa—breast cancer	0.000806	0.00109	CcSEcCtD
Vildagliptin—Malnutrition—Paclitaxel—breast cancer	0.000805	0.00109	CcSEcCtD
Vildagliptin—Fatigue—Thiotepa—breast cancer	0.000805	0.00109	CcSEcCtD
Vildagliptin—Diarrhoea—Vinblastine—breast cancer	0.000805	0.00109	CcSEcCtD
Vildagliptin—Asthenia—Melphalan—breast cancer	0.000803	0.00108	CcSEcCtD
Vildagliptin—Infection—Mitoxantrone—breast cancer	0.000801	0.00108	CcSEcCtD
Vildagliptin—Infection—Irinotecan—breast cancer	0.000801	0.00108	CcSEcCtD
Vildagliptin—Dermatitis bullous—Epirubicin—breast cancer	0.0008	0.00108	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Capecitabine—breast cancer	0.0008	0.00108	CcSEcCtD
Vildagliptin—Constipation—Thiotepa—breast cancer	0.000798	0.00108	CcSEcCtD
Vildagliptin—Flatulence—Paclitaxel—breast cancer	0.000794	0.00107	CcSEcCtD
Vildagliptin—Nervous system disorder—Irinotecan—breast cancer	0.00079	0.00107	CcSEcCtD
Vildagliptin—Oedema—Gemcitabine—breast cancer	0.000785	0.00106	CcSEcCtD
Vildagliptin—Hepatitis—Docetaxel—breast cancer	0.000784	0.00106	CcSEcCtD
Vildagliptin—Hypoglycaemia—Epirubicin—breast cancer	0.000783	0.00106	CcSEcCtD
Vildagliptin—Asthenia—Goserelin—breast cancer	0.000783	0.00106	CcSEcCtD
Vildagliptin—Skin disorder—Mitoxantrone—breast cancer	0.000783	0.00106	CcSEcCtD
Vildagliptin—Diarrhoea—Tamoxifen—breast cancer	0.000782	0.00106	CcSEcCtD
Vildagliptin—Infection—Gemcitabine—breast cancer	0.00078	0.00105	CcSEcCtD
Vildagliptin—Hyperhidrosis—Irinotecan—breast cancer	0.000779	0.00105	CcSEcCtD
Vildagliptin—Hyperhidrosis—Mitoxantrone—breast cancer	0.000779	0.00105	CcSEcCtD
Vildagliptin—Dizziness—Vinblastine—breast cancer	0.000778	0.00105	CcSEcCtD
Vildagliptin—Urticaria—Vinorelbine—breast cancer	0.000776	0.00105	CcSEcCtD
Vildagliptin—Oedema peripheral—Docetaxel—breast cancer	0.000773	0.00104	CcSEcCtD
Vildagliptin—Oedema—Fluorouracil—breast cancer	0.000772	0.00104	CcSEcCtD
Vildagliptin—Connective tissue disorder—Docetaxel—breast cancer	0.000771	0.00104	CcSEcCtD
Vildagliptin—Nervous system disorder—Gemcitabine—breast cancer	0.00077	0.00104	CcSEcCtD
Vildagliptin—Infection—Fluorouracil—breast cancer	0.000767	0.00104	CcSEcCtD
Vildagliptin—Diarrhoea—Melphalan—breast cancer	0.000765	0.00103	CcSEcCtD
Vildagliptin—Skin disorder—Gemcitabine—breast cancer	0.000763	0.00103	CcSEcCtD
Vildagliptin—Nausea—Chlorambucil—breast cancer	0.000762	0.00103	CcSEcCtD
Vildagliptin—Hepatitis—Capecitabine—breast cancer	0.000759	0.00103	CcSEcCtD
Vildagliptin—Hyperhidrosis—Gemcitabine—breast cancer	0.000759	0.00103	CcSEcCtD
Vildagliptin—Nervous system disorder—Fluorouracil—breast cancer	0.000757	0.00102	CcSEcCtD
Vildagliptin—Dizziness—Tamoxifen—breast cancer	0.000755	0.00102	CcSEcCtD
Vildagliptin—Tremor—Paclitaxel—breast cancer	0.000755	0.00102	CcSEcCtD
Vildagliptin—Liver function test abnormal—Methotrexate—breast cancer	0.000754	0.00102	CcSEcCtD
Vildagliptin—Oedema peripheral—Capecitabine—breast cancer	0.000748	0.00101	CcSEcCtD
Vildagliptin—Diarrhoea—Goserelin—breast cancer	0.000747	0.00101	CcSEcCtD
Vildagliptin—Connective tissue disorder—Capecitabine—breast cancer	0.000746	0.00101	CcSEcCtD
Vildagliptin—Urticaria—Thiotepa—breast cancer	0.000741	0.001	CcSEcCtD
Vildagliptin—Dermatitis bullous—Doxorubicin—breast cancer	0.00074	0.001	CcSEcCtD
Vildagliptin—Headache—Vinblastine—breast cancer	0.000737	0.000996	CcSEcCtD
Vildagliptin—Angioedema—Paclitaxel—breast cancer	0.000736	0.000995	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000734	0.000992	CcSEcCtD
Vildagliptin—Hypoglycaemia—Doxorubicin—breast cancer	0.000725	0.00098	CcSEcCtD
Vildagliptin—Dizziness—Goserelin—breast cancer	0.000722	0.000975	CcSEcCtD
Vildagliptin—Headache—Tamoxifen—breast cancer	0.000716	0.000967	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000715	0.000967	CcSEcCtD
Vildagliptin—Angiopathy—Docetaxel—breast cancer	0.000712	0.000962	CcSEcCtD
Vildagliptin—Liver function test abnormal—Epirubicin—breast cancer	0.000706	0.000954	CcSEcCtD
Vildagliptin—Chills—Docetaxel—breast cancer	0.000704	0.000951	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000703	0.00095	CcSEcCtD
Vildagliptin—Asthenia—Vinorelbine—breast cancer	0.000701	0.000948	CcSEcCtD
Vildagliptin—Nausea—Vinblastine—breast cancer	0.000699	0.000944	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Irinotecan—breast cancer	0.000696	0.00094	CcSEcCtD
Vildagliptin—Fatigue—Mitoxantrone—breast cancer	0.000695	0.000939	CcSEcCtD
Vildagliptin—Fatigue—Irinotecan—breast cancer	0.000695	0.000939	CcSEcCtD
Vildagliptin—Pancreatitis—Methotrexate—breast cancer	0.000692	0.000936	CcSEcCtD
Vildagliptin—Constipation—Irinotecan—breast cancer	0.000689	0.000931	CcSEcCtD
Vildagliptin—Constipation—Mitoxantrone—breast cancer	0.000689	0.000931	CcSEcCtD
Vildagliptin—Angiopathy—Capecitabine—breast cancer	0.000689	0.000931	CcSEcCtD
Vildagliptin—Arthralgia—Paclitaxel—breast cancer	0.000686	0.000927	CcSEcCtD
Vildagliptin—Nasopharyngitis—Epirubicin—breast cancer	0.000684	0.000924	CcSEcCtD
Vildagliptin—Headache—Goserelin—breast cancer	0.000684	0.000924	CcSEcCtD
Vildagliptin—Malnutrition—Docetaxel—breast cancer	0.000683	0.000923	CcSEcCtD
Vildagliptin—Chills—Capecitabine—breast cancer	0.000681	0.000921	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000681	0.00092	CcSEcCtD
Vildagliptin—Nausea—Tamoxifen—breast cancer	0.000679	0.000917	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000678	0.000916	CcSEcCtD
Vildagliptin—Fatigue—Gemcitabine—breast cancer	0.000677	0.000915	CcSEcCtD
Vildagliptin—Constipation—Gemcitabine—breast cancer	0.000671	0.000907	CcSEcCtD
Vildagliptin—Asthenia—Thiotepa—breast cancer	0.00067	0.000905	CcSEcCtD
Vildagliptin—Diarrhoea—Vinorelbine—breast cancer	0.000669	0.000904	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000666	0.000901	CcSEcCtD
Vildagliptin—Nausea—Melphalan—breast cancer	0.000664	0.000898	CcSEcCtD
Vildagliptin—Malnutrition—Capecitabine—breast cancer	0.000661	0.000893	CcSEcCtD
Vildagliptin—Oedema—Paclitaxel—breast cancer	0.000657	0.000888	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Methotrexate—breast cancer	0.000656	0.000887	CcSEcCtD
Vildagliptin—Liver function test abnormal—Doxorubicin—breast cancer	0.000653	0.000883	CcSEcCtD
Vildagliptin—Infection—Paclitaxel—breast cancer	0.000653	0.000883	CcSEcCtD
Vildagliptin—Flatulence—Capecitabine—breast cancer	0.000651	0.00088	CcSEcCtD
Vildagliptin—Nausea—Goserelin—breast cancer	0.000648	0.000876	CcSEcCtD
Vildagliptin—Pancreatitis—Epirubicin—breast cancer	0.000648	0.000876	CcSEcCtD
Vildagliptin—Dizziness—Vinorelbine—breast cancer	0.000646	0.000873	CcSEcCtD
Vildagliptin—Nervous system disorder—Paclitaxel—breast cancer	0.000645	0.000871	CcSEcCtD
Vildagliptin—Urticaria—Mitoxantrone—breast cancer	0.00064	0.000865	CcSEcCtD
Vildagliptin—Diarrhoea—Thiotepa—breast cancer	0.000639	0.000863	CcSEcCtD
Vildagliptin—Skin disorder—Paclitaxel—breast cancer	0.000639	0.000863	CcSEcCtD
Vildagliptin—Hyperhidrosis—Paclitaxel—breast cancer	0.000635	0.000859	CcSEcCtD
Vildagliptin—Nasopharyngitis—Doxorubicin—breast cancer	0.000633	0.000855	CcSEcCtD
Vildagliptin—Infestation NOS—Methotrexate—breast cancer	0.00063	0.000851	CcSEcCtD
Vildagliptin—Infestation—Methotrexate—breast cancer	0.00063	0.000851	CcSEcCtD
Vildagliptin—Tremor—Capecitabine—breast cancer	0.000619	0.000837	CcSEcCtD
Vildagliptin—Dizziness—Thiotepa—breast cancer	0.000617	0.000834	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Epirubicin—breast cancer	0.000614	0.00083	CcSEcCtD
Vildagliptin—Urticaria—Fluorouracil—breast cancer	0.000613	0.000829	CcSEcCtD
Vildagliptin—Headache—Vinorelbine—breast cancer	0.000612	0.000827	CcSEcCtD
Vildagliptin—Weight increased—Epirubicin—breast cancer	0.000601	0.000813	CcSEcCtD
Vildagliptin—Pancreatitis—Doxorubicin—breast cancer	0.0006	0.00081	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000599	0.000809	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Methotrexate—breast cancer	0.000595	0.000805	CcSEcCtD
Vildagliptin—Infestation—Epirubicin—breast cancer	0.000589	0.000796	CcSEcCtD
Vildagliptin—Infestation NOS—Epirubicin—breast cancer	0.000589	0.000796	CcSEcCtD
Vildagliptin—Headache—Thiotepa—breast cancer	0.000585	0.00079	CcSEcCtD
Vildagliptin—Arthralgia—Docetaxel—breast cancer	0.000581	0.000785	CcSEcCtD
Vildagliptin—Nausea—Vinorelbine—breast cancer	0.000581	0.000785	CcSEcCtD
Vildagliptin—Asthenia—Mitoxantrone—breast cancer	0.000578	0.000782	CcSEcCtD
Vildagliptin—Asthenia—Irinotecan—breast cancer	0.000578	0.000782	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000577	0.00078	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000568	0.000768	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000568	0.000767	CcSEcCtD
Vildagliptin—Fatigue—Paclitaxel—breast cancer	0.000567	0.000766	CcSEcCtD
Vildagliptin—Hepatitis—Methotrexate—breast cancer	0.000565	0.000764	CcSEcCtD
Vildagliptin—Asthenia—Gemcitabine—breast cancer	0.000563	0.000761	CcSEcCtD
Vildagliptin—Arthralgia—Capecitabine—breast cancer	0.000563	0.00076	CcSEcCtD
Vildagliptin—Constipation—Paclitaxel—breast cancer	0.000562	0.00076	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000559	0.000755	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Epirubicin—breast cancer	0.000557	0.000753	CcSEcCtD
Vildagliptin—Oedema—Docetaxel—breast cancer	0.000557	0.000753	CcSEcCtD
Vildagliptin—Weight increased—Doxorubicin—breast cancer	0.000556	0.000752	CcSEcCtD
Vildagliptin—Nausea—Thiotepa—breast cancer	0.000554	0.000749	CcSEcCtD
Vildagliptin—Infection—Docetaxel—breast cancer	0.000554	0.000748	CcSEcCtD
Vildagliptin—Diarrhoea—Irinotecan—breast cancer	0.000551	0.000745	CcSEcCtD
Vildagliptin—Diarrhoea—Mitoxantrone—breast cancer	0.000551	0.000745	CcSEcCtD
Vildagliptin—Nervous system disorder—Docetaxel—breast cancer	0.000546	0.000738	CcSEcCtD
Vildagliptin—Infestation NOS—Doxorubicin—breast cancer	0.000545	0.000737	CcSEcCtD
Vildagliptin—Infestation—Doxorubicin—breast cancer	0.000545	0.000737	CcSEcCtD
Vildagliptin—Skin disorder—Docetaxel—breast cancer	0.000541	0.000731	CcSEcCtD
Vildagliptin—Oedema—Capecitabine—breast cancer	0.000539	0.000729	CcSEcCtD
Vildagliptin—Diarrhoea—Gemcitabine—breast cancer	0.000537	0.000726	CcSEcCtD
Vildagliptin—Infection—Capecitabine—breast cancer	0.000536	0.000724	CcSEcCtD
Vildagliptin—Dizziness—Irinotecan—breast cancer	0.000533	0.00072	CcSEcCtD
Vildagliptin—Nervous system disorder—Capecitabine—breast cancer	0.000529	0.000715	CcSEcCtD
Vildagliptin—Hepatitis—Epirubicin—breast cancer	0.000529	0.000715	CcSEcCtD
Vildagliptin—Diarrhoea—Fluorouracil—breast cancer	0.000528	0.000714	CcSEcCtD
Vildagliptin—Skin disorder—Capecitabine—breast cancer	0.000524	0.000708	CcSEcCtD
Vildagliptin—Urticaria—Paclitaxel—breast cancer	0.000522	0.000706	CcSEcCtD
Vildagliptin—Hyperhidrosis—Capecitabine—breast cancer	0.000521	0.000705	CcSEcCtD
Vildagliptin—Oedema peripheral—Epirubicin—breast cancer	0.000521	0.000704	CcSEcCtD
Vildagliptin—Connective tissue disorder—Epirubicin—breast cancer	0.00052	0.000702	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Doxorubicin—breast cancer	0.000516	0.000697	CcSEcCtD
Vildagliptin—Angiopathy—Methotrexate—breast cancer	0.000513	0.000693	CcSEcCtD
Vildagliptin—Dizziness—Fluorouracil—breast cancer	0.00051	0.00069	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000508	0.000686	CcSEcCtD
Vildagliptin—Chills—Methotrexate—breast cancer	0.000507	0.000685	CcSEcCtD
Vildagliptin—Headache—Mitoxantrone—breast cancer	0.000505	0.000682	CcSEcCtD
Vildagliptin—Headache—Irinotecan—breast cancer	0.000505	0.000682	CcSEcCtD
Vildagliptin—Malnutrition—Methotrexate—breast cancer	0.000492	0.000665	CcSEcCtD
Vildagliptin—Headache—Gemcitabine—breast cancer	0.000492	0.000665	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000491	0.000664	CcSEcCtD
Vildagliptin—Hepatitis—Doxorubicin—breast cancer	0.000489	0.000661	CcSEcCtD
Vildagliptin—Headache—Fluorouracil—breast cancer	0.000484	0.000654	CcSEcCtD
Vildagliptin—Oedema peripheral—Doxorubicin—breast cancer	0.000482	0.000652	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000481	0.00065	CcSEcCtD
Vildagliptin—Connective tissue disorder—Doxorubicin—breast cancer	0.000481	0.00065	CcSEcCtD
Vildagliptin—Fatigue—Docetaxel—breast cancer	0.00048	0.000649	CcSEcCtD
Vildagliptin—Angiopathy—Epirubicin—breast cancer	0.00048	0.000649	CcSEcCtD
Vildagliptin—Nausea—Irinotecan—breast cancer	0.000479	0.000647	CcSEcCtD
Vildagliptin—Nausea—Mitoxantrone—breast cancer	0.000479	0.000647	CcSEcCtD
Vildagliptin—Constipation—Docetaxel—breast cancer	0.000476	0.000644	CcSEcCtD
Vildagliptin—Chills—Epirubicin—breast cancer	0.000475	0.000641	CcSEcCtD
Vildagliptin—Asthenia—Paclitaxel—breast cancer	0.000472	0.000637	CcSEcCtD
Vildagliptin—Nausea—Gemcitabine—breast cancer	0.000466	0.00063	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000466	0.000629	CcSEcCtD
Vildagliptin—Fatigue—Capecitabine—breast cancer	0.000465	0.000629	CcSEcCtD
Vildagliptin—Constipation—Capecitabine—breast cancer	0.000461	0.000623	CcSEcCtD
Vildagliptin—Malnutrition—Epirubicin—breast cancer	0.00046	0.000622	CcSEcCtD
Vildagliptin—Nausea—Fluorouracil—breast cancer	0.000459	0.00062	CcSEcCtD
Vildagliptin—Flatulence—Epirubicin—breast cancer	0.000454	0.000613	CcSEcCtD
Vildagliptin—Diarrhoea—Paclitaxel—breast cancer	0.00045	0.000608	CcSEcCtD
Vildagliptin—Angiopathy—Doxorubicin—breast cancer	0.000444	0.0006	CcSEcCtD
Vildagliptin—Chills—Doxorubicin—breast cancer	0.000439	0.000594	CcSEcCtD
Vildagliptin—Dizziness—Paclitaxel—breast cancer	0.000435	0.000587	CcSEcCtD
Vildagliptin—Urticaria—Capecitabine—breast cancer	0.000429	0.000579	CcSEcCtD
Vildagliptin—Malnutrition—Doxorubicin—breast cancer	0.000426	0.000576	CcSEcCtD
Vildagliptin—Flatulence—Doxorubicin—breast cancer	0.00042	0.000567	CcSEcCtD
Vildagliptin—Arthralgia—Methotrexate—breast cancer	0.000419	0.000566	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000416	0.000562	CcSEcCtD
Vildagliptin—Headache—Paclitaxel—breast cancer	0.000412	0.000557	CcSEcCtD
Vildagliptin—Asthenia—Docetaxel—breast cancer	0.0004	0.00054	CcSEcCtD
Vildagliptin—Infection—Methotrexate—breast cancer	0.000399	0.000539	CcSEcCtD
Vildagliptin—Nervous system disorder—Methotrexate—breast cancer	0.000394	0.000532	CcSEcCtD
Vildagliptin—Arthralgia—Epirubicin—breast cancer	0.000392	0.00053	CcSEcCtD
Vildagliptin—Nausea—Paclitaxel—breast cancer	0.00039	0.000528	CcSEcCtD
Vildagliptin—Skin disorder—Methotrexate—breast cancer	0.00039	0.000527	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000389	0.000526	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methotrexate—breast cancer	0.000388	0.000525	CcSEcCtD
Vildagliptin—Asthenia—Capecitabine—breast cancer	0.000387	0.000523	CcSEcCtD
Vildagliptin—Diarrhoea—Docetaxel—breast cancer	0.000381	0.000515	CcSEcCtD
Vildagliptin—Oedema—Epirubicin—breast cancer	0.000376	0.000508	CcSEcCtD
Vildagliptin—Infection—Epirubicin—breast cancer	0.000373	0.000505	CcSEcCtD
Vildagliptin—Diarrhoea—Capecitabine—breast cancer	0.000369	0.000499	CcSEcCtD
Vildagliptin—Nervous system disorder—Epirubicin—breast cancer	0.000369	0.000498	CcSEcCtD
Vildagliptin—Dizziness—Docetaxel—breast cancer	0.000368	0.000498	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000366	0.000494	CcSEcCtD
Vildagliptin—Skin disorder—Epirubicin—breast cancer	0.000365	0.000493	CcSEcCtD
Vildagliptin—Hyperhidrosis—Epirubicin—breast cancer	0.000363	0.000491	CcSEcCtD
Vildagliptin—Arthralgia—Doxorubicin—breast cancer	0.000363	0.00049	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.00036	0.000487	CcSEcCtD
Vildagliptin—Dizziness—Capecitabine—breast cancer	0.000357	0.000482	CcSEcCtD
Vildagliptin—Headache—Docetaxel—breast cancer	0.000349	0.000472	CcSEcCtD
Vildagliptin—Oedema—Doxorubicin—breast cancer	0.000348	0.00047	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Methotrexate—breast cancer	0.000347	0.000469	CcSEcCtD
Vildagliptin—Fatigue—Methotrexate—breast cancer	0.000346	0.000468	CcSEcCtD
Vildagliptin—Infection—Doxorubicin—breast cancer	0.000345	0.000467	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000342	0.000463	CcSEcCtD
Vildagliptin—Nervous system disorder—Doxorubicin—breast cancer	0.000341	0.000461	CcSEcCtD
Vildagliptin—Headache—Capecitabine—breast cancer	0.000338	0.000457	CcSEcCtD
Vildagliptin—Skin disorder—Doxorubicin—breast cancer	0.000338	0.000456	CcSEcCtD
Vildagliptin—Hyperhidrosis—Doxorubicin—breast cancer	0.000336	0.000454	CcSEcCtD
Vildagliptin—Nausea—Docetaxel—breast cancer	0.000331	0.000447	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Epirubicin—breast cancer	0.000324	0.000438	CcSEcCtD
Vildagliptin—Fatigue—Epirubicin—breast cancer	0.000324	0.000438	CcSEcCtD
Vildagliptin—Constipation—Epirubicin—breast cancer	0.000321	0.000434	CcSEcCtD
Vildagliptin—Nausea—Capecitabine—breast cancer	0.00032	0.000433	CcSEcCtD
Vildagliptin—Urticaria—Methotrexate—breast cancer	0.000319	0.000431	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000317	0.000428	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Doxorubicin—breast cancer	0.0003	0.000406	CcSEcCtD
Vildagliptin—Fatigue—Doxorubicin—breast cancer	0.0003	0.000405	CcSEcCtD
Vildagliptin—Urticaria—Epirubicin—breast cancer	0.000299	0.000403	CcSEcCtD
Vildagliptin—Constipation—Doxorubicin—breast cancer	0.000297	0.000402	CcSEcCtD
Vildagliptin—Asthenia—Methotrexate—breast cancer	0.000288	0.000389	CcSEcCtD
Vildagliptin—Urticaria—Doxorubicin—breast cancer	0.000276	0.000373	CcSEcCtD
Vildagliptin—Diarrhoea—Methotrexate—breast cancer	0.000275	0.000371	CcSEcCtD
Vildagliptin—Asthenia—Epirubicin—breast cancer	0.00027	0.000364	CcSEcCtD
Vildagliptin—Dizziness—Methotrexate—breast cancer	0.000266	0.000359	CcSEcCtD
Vildagliptin—Diarrhoea—Epirubicin—breast cancer	0.000257	0.000348	CcSEcCtD
Vildagliptin—Headache—Methotrexate—breast cancer	0.000252	0.00034	CcSEcCtD
Vildagliptin—Asthenia—Doxorubicin—breast cancer	0.000249	0.000337	CcSEcCtD
Vildagliptin—Dizziness—Epirubicin—breast cancer	0.000249	0.000336	CcSEcCtD
Vildagliptin—Nausea—Methotrexate—breast cancer	0.000239	0.000322	CcSEcCtD
Vildagliptin—Diarrhoea—Doxorubicin—breast cancer	0.000238	0.000322	CcSEcCtD
Vildagliptin—Headache—Epirubicin—breast cancer	0.000235	0.000318	CcSEcCtD
Vildagliptin—Dizziness—Doxorubicin—breast cancer	0.00023	0.000311	CcSEcCtD
Vildagliptin—Nausea—Epirubicin—breast cancer	0.000223	0.000302	CcSEcCtD
Vildagliptin—Headache—Doxorubicin—breast cancer	0.000218	0.000294	CcSEcCtD
Vildagliptin—Nausea—Doxorubicin—breast cancer	0.000207	0.000279	CcSEcCtD
